Amphastar's intranasal glucagon dry powder, Baqsimi, and Novo Nordisk’s dasiglucagon auto-injector, Zegalogue, compete with Gvoke. McCulloch said he had yet to see the rivals make a big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback